<record>
  <datafield tag="024" ind1="7" ind2=" ">
    <subfield code="a">10.1016/j.apradiso.2016.12.024</subfield>
    <subfield code="2">DOI</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Chakravarty, Rubel</subfield>
    <subfield code="v">Isotope Production and Applications Division, Bhabha Atomic Research Centre, Mumbai 400085, India</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Formulation and purification of therapeutic dose of 90 Y-labeled peptides: Some interesting radiochemistry aspects</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2017-03</subfield>
    <subfield code="t">published</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">5</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Yttrium-90 obtained from most of the 90 Sr/ 90 Y generators contains 90 Sr impurity above permissible limit for human administration. A protocol has been optimized for formulation of therapeutic dose of 90 Y-DOTA-Tyr 3 -octreotate ( 90 Y-DOTA-TATE) and removal of 90 Sr impurity from it. The radiochemical purity of 90 Y-DOTA-TATE was found to be >98% and it met the requirements for clinical use. The radiopharmaceutical was used in preliminary clinical investigation in patients with neuroendocrine tumors. This promising strategy would aid toward widespread clinical utilization of 90 Sr/ 90 Y generators.</subfield>
    <subfield code="9">Elsevier</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="f">Elsevier Ltd</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Neuroendocrine tumors</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">90 Y</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">DOTA-TATE</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Therapeutic dose</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">90 Sr/ 90 Y generator</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Radionuclidic purity</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">90Y</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">90Sr/90Y generator</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Chakraborty, Sudipta</subfield>
    <subfield code="v">Isotope Production and Applications Division, Bhabha Atomic Research Centre, Mumbai 400085, India</subfield>
    <subfield code="m">sudipta@barc.gov.in</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Dash, Ashutosh</subfield>
    <subfield code="v">Isotope Production and Applications Division, Bhabha Atomic Research Centre, Mumbai 400085, India</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="p">Appl.Radiat.Isot.</subfield>
    <subfield code="c">1-5</subfield>
    <subfield code="v">121</subfield>
    <subfield code="y">2017</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">HEP</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">Citeable</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">Published</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Bodei, L.</subfield>
    <subfield code="h">Cremonesi, M.</subfield>
    <subfield code="h">Grana, C.</subfield>
    <subfield code="h">Rocca, P.</subfield>
    <subfield code="h">Bartolomei, M.</subfield>
    <subfield code="h">Chinol, M.</subfield>
    <subfield code="h">Paganelli, G.</subfield>
    <subfield code="t">Receptor radionuclide therapy with 90 Y-[DOTA] 0 -Tyr 3 -octreotide ( 90 Y-DOTATOC) in neuroendocrine tumours</subfield>
    <subfield code="v">31</subfield>
    <subfield code="y">2004</subfield>
    <subfield code="o">Bodei et al, 2004</subfield>
    <subfield code="s">Eur.J.Nucl.Med.Mol.Imaging,31,1038</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Chakravarty, R.</subfield>
    <subfield code="h">Pandey, U.</subfield>
    <subfield code="h">Manolkar, R.B.</subfield>
    <subfield code="h">Dash, A.</subfield>
    <subfield code="h">Venkatesh, M.</subfield>
    <subfield code="h">Pillai, M.R.</subfield>
    <subfield code="t">Development of an electrochemical 90 Sr- 90 Y generator for separation of 90 Y suitable for targeted therapy</subfield>
    <subfield code="v">35</subfield>
    <subfield code="y">2008</subfield>
    <subfield code="o">Chakravarty et al, 2008</subfield>
    <subfield code="s">Nucl.Med.Biol.,35,245</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Chakravarty, R.</subfield>
    <subfield code="h">Dash, A.</subfield>
    <subfield code="h">Pillai, M.R.</subfield>
    <subfield code="t">Availability of yttrium-90 from strontium-90: a nuclear medicine perspective</subfield>
    <subfield code="v">27</subfield>
    <subfield code="y">2012</subfield>
    <subfield code="o">Chakravarty et al, 2012</subfield>
    <subfield code="s">Cancer Biother.Radiopharm.,27,621</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Dash, A.</subfield>
    <subfield code="h">Chakraborty, S.</subfield>
    <subfield code="h">Pillai, M.R.</subfield>
    <subfield code="h">Knapp, F.F.</subfield>
    <subfield code="t">Peptide receptor radionuclide therapy: an overview</subfield>
    <subfield code="v">30</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">Dash et al, 2015</subfield>
    <subfield code="s">Cancer Biother.Radiopharm.,30,47</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Hubalewska-Dydejczyk, A.</subfield>
    <subfield code="h">Jurczak, W.</subfield>
    <subfield code="h">Sowa-Staszczak, A.</subfield>
    <subfield code="h">Kunikowska, J.</subfield>
    <subfield code="h">Krolicki, L.</subfield>
    <subfield code="h">Gilis-Januszewska, A.</subfield>
    <subfield code="h">Giza, A.</subfield>
    <subfield code="h">Szurkowska, M.</subfield>
    <subfield code="h">Pach, D.</subfield>
    <subfield code="h">Glowa, B.</subfield>
    <subfield code="h">Mikolajczak, R.</subfield>
    <subfield code="h">Pawlak, D.</subfield>
    <subfield code="h">Stefanska, A.</subfield>
    <subfield code="h">Huszno, B.</subfield>
    <subfield code="h">Skotnicki, A.B.</subfield>
    <subfield code="t">New forms of radionuclide therapy with 90 Y in oncology</subfield>
    <subfield code="v">11</subfield>
    <subfield code="y">2008</subfield>
    <subfield code="o">Hubalewska-Dydejczyk et al, 2008</subfield>
    <subfield code="s">Nucl.Med.Rev.Cent.East Eur.,11,5</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Kukis, D.L.</subfield>
    <subfield code="h">DeNardo, S.J.</subfield>
    <subfield code="h">DeNardo, G.L.</subfield>
    <subfield code="h">O'Donnell, R.T.</subfield>
    <subfield code="h">Meares, C.F.</subfield>
    <subfield code="t">Optimized conditions for chelation of Yttrium-90-DOTA immunoconjugates</subfield>
    <subfield code="v">39</subfield>
    <subfield code="y">1998</subfield>
    <subfield code="o">Kukis et al, 1998</subfield>
    <subfield code="s">J.Nucl.Med.,39,2105</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Pandey, U.</subfield>
    <subfield code="h">Dhami, P.S.</subfield>
    <subfield code="h">Jagesia, P.</subfield>
    <subfield code="h">Venkatesh, M.</subfield>
    <subfield code="h">Pillai, M.R.</subfield>
    <subfield code="t">Extraction paper chromatography technique for the radionuclidic purity evaluation of 90 Y for clinical use</subfield>
    <subfield code="v">80</subfield>
    <subfield code="y">2008</subfield>
    <subfield code="o">Pandey et al, 2008</subfield>
    <subfield code="s">Anal.Chem.,80,801</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="m">Perkin Elmer Product Sheet: 90 Y. 〈 〉</subfield>
    <subfield code="u">http://www.perkinelmer.com/lab-solutions/resources/docs/FLY_gmp90y_Lu177.pdf</subfield>
    <subfield code="9">refextract</subfield>
    <subfield code="o">Perkin Elmer Product Sheet,</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Puranik, A.D.</subfield>
    <subfield code="h">Kulkarni, H.R.</subfield>
    <subfield code="h">Singh, A.</subfield>
    <subfield code="h">Baum, R.P.</subfield>
    <subfield code="t">Peptide receptor radionuclide therapy with 90 Y/ 177 Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours)</subfield>
    <subfield code="v">42</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">Puranik et al, 2015</subfield>
    <subfield code="s">Eur.J.Nucl.Med.Mol.Imaging,42,1223</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Rogowski, W.</subfield>
    <subfield code="h">Wachula, E.</subfield>
    <subfield code="h">Lewczuk, A.</subfield>
    <subfield code="h">Buscombe, J.R.</subfield>
    <subfield code="h">Seklecka, N.</subfield>
    <subfield code="h">Sankowski, A.</subfield>
    <subfield code="h">Cwikla, J.B.</subfield>
    <subfield code="t">Long-term efficacy of 90 Y-DOTATATE in patients with nonresectable pancreatic and small bowel neuroendocrine neoplasms</subfield>
    <subfield code="v">12</subfield>
    <subfield code="y">2016</subfield>
    <subfield code="o">Rogowski et al, 2016</subfield>
    <subfield code="s">Future Oncol.,12,1877</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Seregni, E.</subfield>
    <subfield code="h">Maccauro, M.</subfield>
    <subfield code="h">Chiesa, C.</subfield>
    <subfield code="h">Mariani, L.</subfield>
    <subfield code="h">Pascali, C.</subfield>
    <subfield code="h">Mazzaferro, V.</subfield>
    <subfield code="h">De Braud, F.</subfield>
    <subfield code="h">Buzzoni, R.</subfield>
    <subfield code="h">Milione, M.</subfield>
    <subfield code="h">Lorenzoni, A.</subfield>
    <subfield code="h">Bogni, A.</subfield>
    <subfield code="h">Coliva, A.</subfield>
    <subfield code="h">Lo Vullo, S.</subfield>
    <subfield code="h">Bombardieri, E.</subfield>
    <subfield code="t">Treatment with tandem [ 90 Y]DOTA-TATE and [ 177 Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy</subfield>
    <subfield code="v">41</subfield>
    <subfield code="y">2014</subfield>
    <subfield code="o">Seregni et al, 2014</subfield>
    <subfield code="s">Eur.J.Nucl.Med.Mol.Imaging,41,223</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Wester, D.W.</subfield>
    <subfield code="h">Steele, R.T.</subfield>
    <subfield code="h">Rinehart, D.E.</subfield>
    <subfield code="h">DesChane, J.R.</subfield>
    <subfield code="h">Carson, K.J.</subfield>
    <subfield code="h">Rapko, B.M.</subfield>
    <subfield code="h">Tenforde, T.S.</subfield>
    <subfield code="t">Large-scale purification of 90 Sr from nuclear waste materials for production of 90Y, a therapeutic medical radioisotope</subfield>
    <subfield code="v">59</subfield>
    <subfield code="y">2003</subfield>
    <subfield code="o">Wester et al, 2003</subfield>
    <subfield code="s">Appl.Radiat.Isot.,59,35</subfield>
  </datafield>
  <datafield tag="FFT" ind1=" " ind2=" ">
    <subfield code="a">/afs/cern.ch/project/inspire/uploads/elsevier/consyn/consyn-files/0969-8043/S0969804316X00139/S0969804316305723/S0969804316305723.xml</subfield>
    <subfield code="t">Elsevier</subfield>
    <subfield code="o">HIDDEN</subfield>
  </datafield>
</record>